Infectious Diseases Search
Infectious Diseases Infectious Diseases

Conference Reports

European Respiratory Society (ERS) International Congress 2018
15 September 2018 - 19 September 2018
22nd International AIDS Conference (AIDS 2018)
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
American Thoracic Society International Conference 2018 (ATS 2018)
San Diego, California, US
18 May 2018 - 23 May 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018)
Madrid, Spain
21 April 2018 - 24 April 2018
National-Dengue-and-Arbovirus-Infection-Conference-2017
Kuala Lumpur, Malaysia
12 August 2017 - 13 August 2017
15th Urological Association of Asia Congress (UAA 2017)
04 August 2017 - 06 August 2017
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Shanghai, China
15 February 2017 - 19 February 2017
49th Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 2016
Athens, Greece
25 May 2016 - 28 May 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Cefiderocol a promising treatment for multidrug-resistant complicated UTI
Tristan Manalac, 06 Nov 2018
Intravenous cefiderocol thrice daily is noninferior to imipenem-cilastatin for treating complicated urinary tract infection (UTI) patients with multidrug-resistant, Gram-negative infections, according to a recent study.
No link between genotype 4 hepatitis E virus and neurologic disorders
01 Nov 2018
Genotype 4 hepatitis E virus infection does not appear to be correlated with acute, nontraumatic neurologic disorders, according to a recent China study.
Sofosbuvir–velpatasvir combo for HCV yields high SVR rate even in absence of ribavirin
01 Nov 2018
In patients with genotype 3 hepatitis C virus (HCV) infection and decompensated cirrhosis, the rate of achieving sustained virologic response 12 weeks after treatment (SVR12) is high with treatment regimens consisting of sofosbuvir and velpatasvir with or without ribavirin, according to the results of a phase II trial. However, the rate appears to be lower in the subgroup of patients with baseline resistance-associated substitutions in nonstructural protein 5A.
Lactobacillus abundance tied to lower risk of childhood wheezing at age 2 years
07 Nov 2018
In infants with early-life acute respiratory infection (ARI) with respiratory syncytial virus (RSV), elevated nasopharyngeal Lactobacillus levels protect against wheezing illnesses at 2 years of age, a recent study has found.